DZ2976A1 - New protease inhibitors, process for their preparation and pharmaceutical compositions containing them - Google Patents

New protease inhibitors, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
DZ2976A1
DZ2976A1 DZ990276A DZ990276A DZ2976A1 DZ 2976 A1 DZ2976 A1 DZ 2976A1 DZ 990276 A DZ990276 A DZ 990276A DZ 990276 A DZ990276 A DZ 990276A DZ 2976 A1 DZ2976 A1 DZ 2976A1
Authority
DZ
Algeria
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
protease inhibitors
new protease
Prior art date
Application number
DZ990276A
Other languages
French (fr)
Inventor
Robert Wells Marquis Jr
Daniel Frank Veber
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DZ2976A1 publication Critical patent/DZ2976A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DZ990276A 1998-12-23 1999-12-22 New protease inhibitors, process for their preparation and pharmaceutical compositions containing them DZ2976A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11414398P 1998-12-23 1998-12-23

Publications (1)

Publication Number Publication Date
DZ2976A1 true DZ2976A1 (en) 2004-03-15

Family

ID=22353596

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990276A DZ2976A1 (en) 1998-12-23 1999-12-22 New protease inhibitors, process for their preparation and pharmaceutical compositions containing them

Country Status (9)

Country Link
EP (1) EP1140897A4 (en)
JP (1) JP2002533452A (en)
AR (1) AR021970A1 (en)
AU (1) AU2713100A (en)
CO (1) CO5180541A1 (en)
DZ (1) DZ2976A1 (en)
HK (1) HK1041690A1 (en)
PE (1) PE20001355A1 (en)
WO (1) WO2000039115A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
WO2001034599A1 (en) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
EP1229914A4 (en) 1999-11-10 2004-06-23 Smithkline Beecham Corp Protease inhibitors
WO2001034600A1 (en) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
NZ520588A (en) 2000-03-21 2004-06-25 Smithkline Beecham Corp Protease inhibitors
US6982263B2 (en) 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases
WO2003075853A2 (en) 2002-03-08 2003-09-18 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
EP1796793A4 (en) * 2004-09-07 2009-08-05 Smithkline Beecham Corp Novel compounds
CN101137412B (en) * 2005-01-13 2012-11-07 布里斯托尔-迈尔斯·斯奎布公司 Substituted biaryl compounds as factor xia inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ2285A1 (en) * 1996-08-08 2002-12-25 Smithkline Beecham Corp Cysteine protease inhibitors.
US6369077B1 (en) * 1997-05-08 2002-04-09 Smithkline Beecham Corporation Protease inhibitors

Also Published As

Publication number Publication date
JP2002533452A (en) 2002-10-08
EP1140897A1 (en) 2001-10-10
HK1041690A1 (en) 2002-07-19
AR021970A1 (en) 2002-09-04
PE20001355A1 (en) 2001-01-28
WO2000039115A1 (en) 2000-07-06
EP1140897A4 (en) 2002-04-03
CO5180541A1 (en) 2002-07-30
AU2713100A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
MA26494A1 (en) NOVEL PROTEASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DZ2773A1 (en) New pyrazolopyrimidinones process for their preparation and pharmaceutical compositions containing them.
DZ2890A1 (en) 4-Carboxamino-2-substituted-1,2,3,4-tetrahydroquinoline, process for their preparation and pharmaceutical compositions containing them.
MA26551A1 (en) NOVEL PROSTAGLANDIN AGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2748026B1 (en) NOVEL METALLOPROTEASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2780057B1 (en) PHENOXYPROPANOLAMINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26743A1 (en) NEW METALLOPROTEASE INHIBITOR COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DZ2889A1 (en) 4-Carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines, process for their preparation and pharmaceutical compositions containing them.
DZ2891A1 (en) New substituted tetrahydroquinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2634A1 (en) New pleuromutilin derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2866A1 (en) New 1-Aryl-3-arylmethyl-1,8-naphthyridine-4- (1H) -ones, process for their preparation and pharmaceutical compositions containing them.
MA26630A1 (en) NOVEL 4-PHENYLPYPERIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DZ2523A1 (en) Pharmaceutical formulations containing voriconazole and process for their preparation.
CH689805A8 (en) Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it.
DZ2963A1 (en) New substituted bicyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2465A1 (en) New pyrazolopyrimidinones process for their preparation and compositions containing them.
DZ2197A1 (en) 6-Phenylpyridyl-2-amine derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ1889A1 (en) New quinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ3020A1 (en) New oxamic acids, process for their preparation and pharmaceutical compositions containing them.
MA26472A1 (en) N-HYDROXY-B-SULFONYLPROPIONAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DZ3045A1 (en) Novel i-3-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2777A1 (en) New quinazolinamine derivatives process for their preparation and pharmaceutical compositions containing them.
MA26514A1 (en) PROSTAGLANDIN AGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DZ2894A1 (en) Pharmaceutical compositions containing pyridol Ä1,2-AÜpyrazine derivatives and process for their repair.
DZ2944A1 (en) New azalides, process for their preparation and pharmaceutical compositions containing them.